Healthcare & Life Sciences

Herbalife's new podcast with Paralympian Palak Kohli reveals a deeper trend: how corporate content is fueling a new ecosystem for para-athletes in India.

Major hotel chains are now building integrated living ecosystems for digital nomads. What does this pivot to wellness mean for the future of care?

A new neuroscience framework reveals why ethical leaders attract criticism, shifting the focus from leadership flaws to the observer's own brain.

PathAI's AIM-MASH tool just got dual FDA/EMA approval, a first for AI pathology. This could slash MASH drug development time and reshape clinical trials.

A $170M deal to boost infant formula supply has soured for Perrigo, leading to a 25% stock crash, a strategic review, and securities fraud lawsuits.

A new partnership between evermore and Vallarta Supermarkets isn't just about groceries; it's about using tech to deliver health equity with cultural dignity.

One company's move to standardize a traditional remedy highlights a key strategy for winning trust and market share in the booming wellness industry.

NMI launches Business Capital, an embedded lending tool giving healthcare providers fast access to funds. Is this the lifeline the industry needs?

J.P. Morgan's 2026 outlook reveals how private markets, fueled by AI, are rebuilding the physical backbone of the global supply chain.

In post-acute care, is training enough? A new digital platform aims to verify caregiver skills at the bedside, tackling both compliance and care quality.

Facing federal overhaul and public outcry, top organizations pledge reform. Can innovation and transparency fix a broken system and save thousands of lives?

A new study reveals a simple dietary change—swapping carb snacks for tree nuts—can curb cravings for junk food and improve health in young adults.

A landmark demonstration of 'unhackable' quantum communication on a live network signals a paradigm shift for protecting sensitive healthcare data.

Cohere Health's new Policy Studio uses AI to digitize archaic medical policies, promising to cut costs, ease provider burden, and meet new regulations.

iCIMS is #1 in the booming ATS market, but its real advantage isn't just AI. It's a validated, responsible approach that's winning over enterprise clients.

With its 2026 Investor Day nearing, PHINIA aims to prove its dual-path strategy is the key to powering a diverse, carbon-conscious industrial future.

Eli Lilly's takeover of Adverum signals a major push into ocular gene therapy. Can a one-time injection for vision loss disrupt a multi-billion dollar market?

A new federal hemp ban is set to fail, warns a CRS report. Experts say a lack of funding and data infrastructure could create a dangerous black market.

A startup claims to solve AI's 95% pilot failure rate with a self-improving engine. We analyze if this is the key to unlocking true enterprise AI.

Beyond sponsorship, Kodiak's U.S. Ski & Snowboard deal is a calculated investment to dominate the lifestyle nutrition market by fueling Olympic dreams.